Andrew L. Kung, MD, PhD

Publications

• Tseng JC, Wang Y, Banerjee P, Kung AL.Incongruity of Imaging Using Fluorescent 2-DG Conjugates Compared to (18)F-FDG in Preclinical Cancer Models.Mol Imaging Biol. 2012 Feb 3.
  22302178
• Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner J
  21889194
• Ziegler DS, Keating J, Kesari S, Fast EM, Zawel L, Ramakrishna N, Barnes J, Kieran MW, Veldhuijzen van Zanten SE, Kung AL.A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.Neuro Oncology.
  21724651
• Bernt KM, Zhu N, Sinha AU, Vempati S, Faber J, Krivtsov AV, Feng Z, Punt N, Daigle A, Bullinger L, Pollock RM, Richon VM, Kung AL, Armstrong SA.MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.Cancer Cell. 2011 Jul 12;20(1):66-7
  21741597
• Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, Agoston ES, Reynoird N, Khochbin S, Ince TA, Christie A, Janeway KA, Vargas SO, Perez-Atayde AR, Aster JC, Sallan SE, Kung AL, Bradner JE, French CA.Differentiation of NUT Midline Carcinoma
  21447744
• Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, Xiao Y, Christie AL, Aster J, Settleman J, Gygi SP, Kung AL, Look T, Nakayama KI, DePinho RA, Wei W.SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for u
  21368833
• Runnels JM, Carlson AL, Pitsillides C, Thompson B, Wu J, Spencer JA, Kohler JM, Azab A, Moreau AS, Rodig SJ, Kung AL, Anderson KC, Ghobrial IM, Lin CP.Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy.J Biomed O
  21280893
• Chaponis D, Barnes JW, Dellagatta JL, Kesari S, Fast E, Sauvageot C, Panagrahy D, Greene ER, Ramakrishna N, Wen PY, Kung AL, Stiles C, Kieran MW.Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas.J.
  21246394
• Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knap
  20871596
• Chen Z, Sasaki T, Tan X, Carretero J, Shimamura T, Li D, Xu C, Wang Y, Aldelmant GO, Capelletti M, Lee HJ, Rodig SJ, Borgman CL, Park SI, Kim HR, Padera RF, Marto J, Gray N, Kung AL, Shapiro GI, Janne PA, Wong KK.Inhibition of ALK, PI3K/MEK and HSP90 in M
  20952506
• Bernal F, Wade M, Godes M, Davis TN, Whitehead DG, Kung AL, Wahl GM, Walensky LD.A stapled p53 helix overcomes HDMX-mediated suppression of p53.Cancer Cell. 2010 Nov 16;18(5):411-22.
  21075307
• Weisberg E, Choi HG, Barrett R, Zhou W, Zhang J, Ray A, Nelson EA, Jiang J, Moreno D, Stone R, Galinsky I, Fox E, Adamia S, Kung AL, Gray NS, Griffin JD.Discovery and characterization of novel mutant FLT3 kinase inhibitors.Mol Cancer Ther. 2010 Sep;9(9):2
  20807780
• Weisberg E, Choi HG, Ray A, Barrett R, Zhang J, Sim T, Zhou W, Seeliger M, Cameron M, Azam M, Fletcher JA, Debiec-Rychter M, Mayeda M, Moreno D, Kung AL, Janne PA, Khosravi-Far R, Melo JV, Manley P, Adamia S, Wu C, Gray N, Griffin JD.Discovery of a small
  20299508
• McMillin DW, Delmore J, Weisberg E, Negri JM, Geer DC, Klippel S, Mitsiades N, Schlossman RL, Munshi NC, Kung AL, Griffin JD, Richardson PG, Anderson KC, Mitsiades CS.Tumor cell-specific bioluminescence platform to identify stroma-induced changes to antic
  20228816
• Sheng Q, Liu X, Fleming E, Yuan K, Piao H, Chen J, Moustafa Z, Thomas RK, Greulich H, Schinzel A, Zaghlul S, Batt D, Ettenberg S, Meyerson M, Schoeberl B, Kung AL, Hahn WC, Drapkin R, Livingston DM, Liu JF.An activated ErbB3/NRG1 autocrine loop supports i
  20227043
• Kimbrel EA, Lemieux ME, Xia X, Davis TN, Rebel VI, Kung AL.Systematic in vivo structure-function analysis of p300 in hematopoiesis.Blood. 2009 Nov 26;114(23):4804-12.
  19822904
• Xia X, Kung AL.Preferential binding of HIF-1 to transcriptionally active loci determines cell-type specific response to hypoxia.Genome Biol. 2009;10(10):R113.
  19828020
• Moellering RE, Cornejo M, Davis TN, Del Bianco C, Aster JC, Blacklow SC, Kung AL, Gilliland DG, Verdine GL, Bradner JE.Direct inhibition of the NOTCH transcription factor complex.Nature. 2009 Nov 12;462(7270):182-8.
  19907488
• Shi D, Pop MS, Kulikov R, Love IM, Kung AL, Kung A, Grossman SR.CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53.Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16275-80.
  19805293
• Hahn CK, Berchuck JE, Ross KN, Kakoza RM, Clauser K, Schinzel AC, Ross L, Galinsky I, Davis TN, Silver SJ, Root DE, Stone RM, DeAngelo DJ, Carroll M, Hahn WC, Carr SA, Golub TR, Kung AL, Stegmaier K.Proteomic and genetic approaches identify Syk as an AML
  19800574
• Kimbrel EA, Davis TN, Bradner JE, Kung AL.In vivo pharmacodynamic imaging of proteasome inhibition.Mol Imaging.;8(3):140-7.
  19723471
• Kim WY, Perera S, Zhou B, Carretero J, Yeh JJ, Heathcote SA, Jackson AL, Nikolinakos P, Ospina B, Naumov G, Brandstetter KA, Weigman VJ, Zaghlul S, Hayes DN, Padera RF, Heymach JV, Kung AL, Sharpless NE, Kaelin WG, Wong KK.HIF2alpha cooperates with RAS to
  19662677
• Corsello SM,Roti G,Ross KN,Chow KT,Galinsky I,Deangelo DJ,Stone RM,Kung AL,Golub TR,Stegmaier K.Identification of AML1-ETO modulators by chemical genomics.Blood. 2009 Jun 11;113(24):6193-205.
  19377049
• Migita T,Ruiz S,Fornari A,Fiorentino M,Priolo C,Zadra G,Inazuka F,Grisanzio C,Palescandolo E,Shin E,Fiore C,Xie W,Kung AL,Febbo PG,Subramanian A,Mucci L,Ma J,Signoretti S,Stampfer M,Hahn WC,Finn S,Loda M.Fatty acid synthase: a metabolic enzyme and candida
  19318631
• Kimbrel EA,Kung AL.The F-box Protein {beta}-TrCp1/Fbw1a Interacts with p300 to Enhance {beta}-Catenin Transcriptional Activity.J Biol Chem. 2009 May 8;284(19):13033-44.
  19297328
• Xia X,Lemieux ME,Li W,Carroll JS,Brown M,Liu XS,Kung AL.Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis.Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4260-5.
  19255431
• Yang J,Bielenberg DR,Rodig SJ,Doiron R,Clifton MC,Kung AL,Strong RK,Zurakowski D,Moses MA.Lipocalin 2 promotes breast cancer progression.Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3913-8.
  19237579
• Azab AK,Runnels JM,Pitsillides C,Moreau AS,Azab F,Leleu X,Jia X,Wright R,Ospina B,Carlson AL,Alt C,Burwick N,Roccaro AM,Ngo HT,Farag M,Melhem MR,Sacco A,Munshi NC,Hideshima T,Rollins BJ,Anderson KC,Kung AL,Lin CP,Ghobrial IM.CXCR4 inhibitor AMD3100 disrup
  19139079
• Kolesnikova TV,Kazarov AR,Lemieux ME,Lafleur MA,Kesari S,Kung AL,Hemler ME.Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.Neoplasia. 2009 Jan;11(1):77-86, 4p following 86.
  19107234
• Du J,Bernasconi P,Clauser KR,Mani DR,Finn SP,Beroukhim R,Burns M,Julian B,Peng XP,Hieronymus H,Maglathlin RL,Lewis TA,Liau LM,Nghiemphu P,Mellinghoff IK,Louis DN,Loda M,Carr SA,Kung AL,Golub TR.Bead-based profiling of tyrosine kinase phosphorylation ident
  19098899
• Faber J,Krivtsov AV,Stubbs MC,Wright R,Davis TN,van den Heuvel-Eibrink M,Zwaan CM,Kung AL,Armstrong SA.HOXA9 is required for survival in human MLL-rearranged acute leukemias.Blood. 2009 Mar 12;113(11):2375-85.
  19056693
• Krivtsov AV,Feng Z,Lemieux ME,Faber J,Vempati S,Sinha AU,Xia X,Jesneck J,Bracken AP,Silverman LB,Kutok JL,Kung AL,Armstrong SA.H3K79 methylation profiles define murine and human MLL-AF4 leukemias.Cancer Cell. 2008 Nov 4;14(5):355-68.
  18977325
• Weisberg E,Roesel J,Bold G,Furet P,Jiang J,Cools J,Wright RD,Nelson E,Barrett R,Ray A,Moreno D,Hall-Meyers E,Stone R,Galinsky I,Fox E,Gilliland G,Daley JF,Lazo-Kallanian S,Kung AL,Griffin JD.Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST
  18820131
• Sauvageot CM,Weatherbee JL,Kesari S,Winters SE,Barnes J,Dellagatta J,Ramakrishna NR,Stiles CD,Kung AL,Kieran MW,Wen PY.Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.Neuro-oncol. 2009 Apr;11(2):109-21.
  18682579
• Ziegler DS,Wright RD,Kesari S,Lemieux ME,Tran MA,Jain M,Zawel L,Kung AL.Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins.J Clin Invest. 2008 Sep;118(9):3109-22.
  18677408
• Yokoyama S,Feige E,Poling LL,Levy C,Widlund HR,Khaled M,Kung AL,Fisher DE.Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.Pigment Cell Melanoma Res. 2008 Aug;21(4):457-63.
  18627530
• Hahn CK,Ross KN,Warrington IM,Mazitschek R,Kanegai CM,Wright RD,Kung AL,Golub TR,Stegmaier K.Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.Proc Natl Acad Sci U S A.
  18607002
• Lee J, Hagerty S, Cormier KA, Ferrante RJ, Kung AL, Ryu H.Monoallele Deletion of CBP Leads to Pericentromeric Heterochromatin Condensation through ESET Expression and Histone H3 (K9) Methylation.Hum Mol Genet. 2008 Jun 15;17(12):1774-82.
  18319327
• Weisberg E, Wright RD, McMillin DW, Mitsiades C, Ray A, Barrett R, Adamia S, Stone R, Galinsky I, Kung AL, Griffin JD.Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.Mol Cancer Ther. 2008 May;7(5):1121-9.
  18445657
• Ziegler DS, Kung AL, Kieran MW.Anti-apoptosis mechanisms in malignant gliomas.J Clin Oncol. 2008 Jan 20;26(3):493-500. Review.
  18202424
• Weisberg E, Banerji L, Wright RD, Barrett R, Ray A, Moreno D, Catley L, Jiang J, Hall-Meyers E, Sauveur-Michel M, Stone R, Galinsky I, Fox E, Kung AL, Griffin JD.Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on B
  18184863
• Ziegler DS, Kung AL.Therapeutic targeting of apoptosis pathways in cancer.Curr Opin Oncol. 2008 Jan;20(1):97-103. Review.
  18043263
• Stubbs MC, Kim YM, Krivtsov AV, Wright RD, Feng Z, Agarwal J, Kung AL, Armstrong SA.MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.Leukemia. 2008 Jan;22(1):66-77.
  17851551
• Weisberg E, Kung AL, Wright RD, Moreno D, Catley L, Ray A, Zawel L, Tran M, Cools J, Gilliland G, Mitsiades C, McMillin DW, Jiang J, Hall-Meyers E, Griffin JD.Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressin
  17620426
• Stegmaier K, Wong JS, Ross KN, Chow KT, Peck D, Wright RD, Lessnick SL, Kung AL, Golub TR.Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.PLoS Med. 2007 Apr;4(4):e122.
  17425403
• Kung AL.Practices and pitfalls of mouse cancer models in drug discovery.Adv Cancer Res. 2007;96:191-212. Review.
  17161681
• Torres-Arzayus MI, Yuan J, DellaGatta JL, Lane H, Kung AL, Brown M.Targeting the AIB1 oncogene through mammalian target of rapamycin inhibition in the mammary gland.Cancer Res. 2006 Dec 1;66(23):11381-8.
  17145884
• Redjal N, Chan JA, Segal RA, Kung AL.CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas.Clin Cancer Res. 2006 Nov 15;12(22):6765-71.
  17121897
• Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM, Jia X, Lu G, Timm M, Kumar A, Côté D, Veilleux I, Hedin KE, Roodman GD, Witzig TE, Kung AL, Hideshima T, Anderson KC, Lin CP, Ghobrial IM.Mechanisms of
  17119115
• Weisberg E, Wright RD, Jiang J, Ray A, Moreno D, Manley PW, Fabbro D, Hall-Meyers E, Catley L, Podar K, Kung AL, Griffin JD.Effects of PKC412, nilotinib, and imatinib against GIST-associated PDGFRA mutants with differential imatinib sensitivity.Gastroente
  17087936
• Weisberg E, Catley L, Wright RD, Moreno D, Banerji L, Ray A, Manley PW, Mestan J, Fabbro D, Jiang J, Hall-Meyers E, Callahan L, DellaGatta JL, Kung AL, Griffin JD.Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leu
  17068153
• Redjal N, Chan JA, Segal RA, Kung A.CXCR4 inhibtion syniergizes with cytotoxic chemotherapy in gliomas.J Am Diet Assoc. 2006 Summer;In Press:In Press.
• Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT, Lessnick SL, Linehan WM, Kung AL, Fisher DE.Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.Cancer Cell. 200
  16766266
• Becker CM, Wright RD, Satchi-Fainaro R, Funakoshi T, Folkman J, Kung AL, D'Amato RJ.A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.Am J Pathol. 2006 Jun;168(6):2074-84.
  16723720
• Almog N, Henke V, Flores L, Hlatky L, Kung AL, Wright RD, Berger R, Hutchinson L, Naumov GN, Bender E, Akslen LA, Achilles EG, Folkman J.Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis.FASEB J. 2006 May;20(7):947-9.
  16638967
• Szentirmai O, Baker CH, Lin N, Szucs S, Takahashi M, Kiryu S, Kung AL, Mulligan RC, Carter BS.Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and
  16462491
• Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Kung AL, Davies FE, Morgan G, Akiyama M, Shringarpure R, Munshi NC, Richardson PG, Hideshima T, Chauhan D, Gu X, Bailey C, Joseph M, Libermann TA, Rosen NS, Anderson KC.Anti-myeloma activity of heat shoc
  16234364
• Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB.Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies.Cancer Res. 2005 Dec 15;65(24):11392-9.
  16357147
• Tang Y, Kim M, Carrasco D, Kung AL, Chin L, Weissleder R.In vivo assessment of RAS-dependent maintenance of tumor angiogenesis by real-time magnetic resonance imaging.Cancer Res. 2005 Sep 15;65(18):8324-30.
  16166309
• Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS, Hodin R, Heitritter S, Moore F, Dluhy R, Sosa JA, Ocal IT, Benn DE, Marsh DJ, Robinson BG, Schneider K, Garber J, Arum SM, Korbonits M, Grossma
  16103922
• Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, Livingston DM, Rajewsky K.Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing.Genes Dev. 2005 Feb 15;19(4):489-501.
  15713842
• Weisberg E, Manley PW, Breitenstein W, Brüggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Mohammed A, Neuberg D, Wright RD, Gilliland DG, Griffin JD.Charac
  15710326
• Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, Wright RD, Wagner G, Verdine GL, Korsmeyer SJ.Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.Science. 2004 Sep 3;305(5689):1466-70.
  15353804
• Kung AL, Zabludoff SD, France DS, Freedman SJ, Tanner EA, Vieira A, Cornell-Kennon S, Lee J, Wang B, Wang J, Memmert K, Naegeli HU, Petersen F, Eck MJ, Bair KW, Wood AW, Livingston DM.Small molecule blockade of transcriptional coactivation of the hypoxia-
  15261140
• Poulin DL, Kung AL, DeCaprio JA.p53 targets simian virus 40 large T antigen for acetylation by CBP.J Virol. 2004 Aug;78(15):8245-53.
  15254196
• Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Akiyama M, Hideshima T, Chauhan D, Joseph M, Libermann TA, García-Echeverría C, Pearson MA, Hofmann F, Anderson KC, Kung AL.Inhibition of the insulin-like growth factor receptor-1 tyrosin
  15050914
• Safran M, Kim WY, Kung AL, Horner JW, DePinho RA, Kaelin WG.Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination.Mol Imaging. 2003 Oct;2(4):297-302.
  14717328
• Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA.A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8.
  14595012
• Freedman SJ, Sun ZY, Kung AL, France DS, Wagner G, Eck MJ.Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.Nat Struct Biol. 2003 Jul;10(7):504-12.
  12778114
• Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM.Polyubiquitination of p53 by a ubiquitin ligase activity of p300.Science. 2003 Apr 11;300(5617):342-4.
  12690203
• Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ.Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classif
  12620411
• Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM.Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal.Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14789-94.
  12397173
• Freedman SJ, Sun ZY, Poy F, Kung AL, Livingston DM, Wagner G, Eck MJ.Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha.Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5367-72.
  11959990
• Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, Kung AL, Cereb N, Yao TP, Yang SY, Reiner SL.Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.Science. 2001 Jun 8;292(5523):1907-10.
  11397944
• Tse WT, Tang J, Jin O, Korsgren C, John KM, Kung AL, Gwynn B, Peters LL, Lux SE.A new spectrin, beta IV, has a major truncated isoform that associates with promyelocytic leukemia protein nuclear bodies and the nuclear matrix.J Biol Chem. 2001 Jun 29;276(2
  11294830
• Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM.Suppression of tumor growth through disruption of hypoxia-inducible transcription.Nat Med. 2000 Dec;6(12):1335-40.
  11100117
• Eid JE, Kung AL, Scully R, Livingston DM.p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion.Cell. 2000 Sep 15;102(6):839-48.
  11030627
• Falvo JV, Brinkman BM, Tsytsykova AV, Tsai EY, Yao TP, Kung AL, Goldfeld AE.A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor alpha gene expression.Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):3925-9
  10760264
• Kung AL, Rebel VI, Bronson RT, Ch'ng LE, Sieff CA, Livingston DM, Yao TP.Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP.Genes Dev. 2000 Feb 1;14(3):272-7.
  10673499
• Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM.Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.Genes Dev. 1999 Jan 1;13(1):64-75.
  9887100
• Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM, Livingston DM.p300/MDM2 complexes participate in MDM2-mediated p53 degradation.Mol Cell. 1998 Oct;2(4):405-15.
  9809062